Trial
NCT05358691
A Trial of AN0025 With Chemoradiation Therapy in Stage III NSCLC Participants
Phase IWITHDRAWNOTHER/UNKNOWNConfidence: LOW
Sponsor
Rutgers, The State University of New Jersey
Collaborators
Adlai Nortye Biopharma Co., Ltd.
Condition
Lung Cancer Stage III
Intervention
AN0025
Why stopped
The research was cancelled
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2025-04-16